Loading clinical trials...
Loading clinical trials...
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Long Lesion Sub-trial
Conditions
Interventions
PROMUS Element Coronary Stent System
Aspirin
+1 more
Locations
30
United States
Scripps Clinic
La Jolla, California, United States
Mercy General Hospital
Sacramento, California, United States
Alvarado Hospital
San Diego, California, United States
MediQuest Research Group Inc. at Munroe Regional Medical Center
Ocala, Florida, United States
Florida Hospital
Orlando, Florida, United States
Maine Medical Center
Portland, Maine, United States
Start Date
February 1, 2009
Primary Completion Date
March 1, 2011
Completion Date
May 1, 2015
Last Updated
March 26, 2019
NCT07329699
NCT06863155
NCT06779630
NCT05461729
NCT07493603
NCT03854071
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions